Cargando…

Adoptive Cell Therapy: A Novel and Potential Immunotherapy for Glioblastoma

Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults with very poor prognosis and few advances in its treatment. Recently, fast-growing cancer immunotherapy provides a glimmer of hope for GBM treatment. Adoptive cell therapy (ACT) aims at infusing immune cells with direct a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jingyu, Shen, Fang, Yao, Ying, Wang, Lin-lin, Zhu, Yongjian, Hu, Jue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005203/ https://www.ncbi.nlm.nih.gov/pubmed/32083009 http://dx.doi.org/10.3389/fonc.2020.00059

Ejemplares similares

Adoptive Cell Therapies for Glioblastoma
por: Bielamowicz, Kevin, et al.
Publicado: (2013)

Cytomegalovirus as a Novel Target for Immunotherapy of Glioblastoma Multiforme
por: Schuessler, Andrea, et al.
Publicado: (2014)

Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma
por: Jain, Saket, et al.
Publicado: (2022)

Development of CAR-T Cell Persistence in Adoptive Immunotherapy of Solid Tumors
por: Fan, Jiaqiao, et al.
Publicado: (2021)

Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme
por: Chin, Christopher, et al.
Publicado: (2018)

Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma
por: Rajani, Karishma R., et al.
Publicado: (2019)

NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma
por: Wang, Yuekun, et al.
Publicado: (2020)

Photothermal Therapy for the Treatment of Glioblastoma: Potential and Preclinical Challenges
por: Bastiancich, Chiara, et al.
Publicado: (2021)

Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
por: Klein, Eliane, et al.
Publicado: (2020)

Efficacy of Cytokine-Induced Killer Cell Immunotherapy for Patients With Pathologically Pure Glioblastoma
por: Han, Myung-Hoon, et al.
Publicado: (2022)

The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme
por: Daei Sorkhabi, Amin, et al.
Publicado: (2022)

TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation
por: Zang, Kui, et al.
Publicado: (2021)

Co-expression prognostic-related genes signature base on propofol and sevoflurane anesthesia predict prognosis and immunotherapy response in glioblastoma
por: Hou, Zhiqi, et al.
Publicado: (2023)

Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma
por: Hu, Boyu, et al.
Publicado: (2018)

Stem cell-derived mitochondria transplantation: a novel strategy and the challenges for the treatment of tissue injury
por: Wang, Jingyu, et al.
Publicado: (2018)

Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy
por: Xu, Chunfeng, et al.
Publicado: (2021)

CAR-NK cell therapy for glioblastoma: what to do next?
por: Xiong, Qi, et al.
Publicado: (2023)

Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma
por: Zhao, Li-ming, et al.
Publicado: (2023)

Resveratrol analog, triacetylresveratrol, a potential immunomodulator of lung adenocarcinoma immunotherapy combination therapies
por: He, Jian, et al.
Publicado: (2023)

Construction of Novel Methylation-Driven Gene Model and Investigation of PARVB Function in Glioblastoma
por: Yu, Wanli, et al.
Publicado: (2021)

A Comparative Retrospective Study of Immunotherapy RANO Versus Standard RANO Criteria in Glioblastoma Patients Receiving Immune Checkpoint Inhibitor Therapy
por: Chen, Xin, et al.
Publicado: (2021)

Mitochondria-Targeting Immunogenic Cell Death Inducer Improves the Adoptive T-Cell Therapy Against Solid Tumor
por: Jiang, Qingzhi, et al.
Publicado: (2019)

LASTR is a novel prognostic biomarker and predicts response to cancer immunotherapy in gastric cancer
por: Liu, Jun-Yan, et al.
Publicado: (2022)

Novel Immunotherapies for Osteosarcoma
por: Lu, Yubao, et al.
Publicado: (2022)

Novel considerations on EGFR-based therapy as a contributor to cancer cell death in NSCLC
por: Peng, Weiwei, et al.
Publicado: (2023)

MRI radiomics and potential applications to glioblastoma
por: Hooper, Grayson W., et al.
Publicado: (2023)

Exosomes and cancer immunotherapy: A review of recent cancer research
por: Cao, Yue, et al.
Publicado: (2023)

B7 Family Members in Lymphoma: Promising Novel Targets for Tumor Immunotherapy?
por: Zhang, Wei, et al.
Publicado: (2021)

ErbB2/Her2-specific NK cells for adoptive immunotherapy of glioblastoma
por: Zhang, Congcong, et al.
Publicado: (2014)

Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment
por: Vu, Son Hai, et al.
Publicado: (2023)

Immune Checkpoints and Innovative Therapies in Glioblastoma
por: Romani, Massimo, et al.
Publicado: (2018)

Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2020)

Impact of cytotoxic T lymphocytes immunotherapy on prognosis of colorectal cancer patients
por: Zhu, Yankun, et al.
Publicado: (2023)

Application Of Adoptive Immunotherapy In Ovarian Cancer
por: Yang, Siyu, et al.
Publicado: (2019)

Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer
por: Pu, Dan, et al.
Publicado: (2021)

Molecular Heterogeneity in Glioblastoma: Potential Clinical Implications
por: Parker, Nicole Renee, et al.
Publicado: (2015)

Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy
por: Tang, Xuejia, et al.
Publicado: (2021)

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2019)

Current Advances in Immunotherapy for Glioblastoma
por: Mende, Abigail L., et al.
Publicado: (2021)

Optimal Therapies for Recurrent Glioblastoma: A Bayesian Network Meta-Analysis
por: Chen, Wenlin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7650ug28lcakt63m4jfevqqk1j